A modern clinic for at-home treatments
(857) 240-1080
! Not medical advice. Consult a doctor.







Montelukast, known commercially as Singulair ODT, is a medication that belongs to the class of drugs called leukotriene receptor antagonists. This drug plays a significant role in managing various respiratory conditions by blocking the actions of leukotrienes, substances in the body that cause asthma and allergic rhinitis symptoms.
Uses of Montelukast (Singulair ODT)
Montelukast is used primarily for the prevention and long-term management of asthma in adults and children. Additionally, it is used to relieve symptoms of allergic rhinitis, commonly known as hay fever.
Conditions Treated
Why settle for temporary relief? Try immunotherapy for lasting results!
Am I eligible?
Montelukast, commonly marketed as Singulair ODT, is a medication primarily used to manage and treat a variety of persistent conditions related to allergies and asthma. Here are the key conditions it addresses:
Asthma Management
Allergic Rhinitis
Urticaria (Chronic Hives)
Important Considerations
Find out if immunotherapy is right for you

Benefits of Using Montelukast (Singulair ODT)

Montelukast (Singulair ODT) Side Effects
Safety Precautions When Using Montelukast (Singulair ODT)
A safer solution to allergies: try immunotherapy today!

Immunotherapy and medications like Montelukast (Singulair ODT) serve as treatments for allergies, but immunotherapy presents some distinct advantages.
Long-term Relief
Reduces Medication Dependency
Improved Quality of Life
Potential for Disease Modification
Wide-ranging Benefits

Treatment prescribed
by clinician


Clinicaly made allergen extracts are customized for your allergies


Your immune system gets desensitized to allergens, giving you long-term relief.
Medical disclaimer.
This page is for educational purposes only and is not medical advice, diagnosis, or treatment. It is not a substitute for consultation with a licensed healthcare provider. Always talk to a qualified clinician before starting, stopping, or changing any allergy treatment. Outcomes from allergy immunotherapy vary from patient to patient. Response rates, symptom-reduction percentages, timelines, and pricing referenced on this page are based on peer-reviewed literature, clinical guidelines, and current Curex membership plans at the time of review - they are population averages or current offers, not a prediction of individual results, and are subject to change. Eligibility for any treatment is determined by a licensed clinician on a case-by-case basis. Cntent reviewed by a licensed clinician. References to third-party products, brand names, or competitor services are for educational comparison only and do not imply endorsement.